| mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
7e-05 |
| mRNA |
AZ628 |
GDSC1000 |
pan-cancer |
AAC |
-0.2 |
8e-05 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0001 |
| mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0004 |
| mRNA |
AS605240 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0007 |
| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
0.0007 |
| mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
| mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.001 |
| mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |